Standard Practice for Sampling Liquefied Petroleum (LP) Gases (Manual Method)
|Publication Date:||1 May 2004|
|ICS Code (Gaseous fuels):||75.160.30|
This practice covers equipment and procedures for obtaining a representative sample of specification Liquefied Petroleum Gas (LPG), such as specified in Specification D 1835, GPA 2140, and comparable international standards.
This practice is suitable for obtaining representative samples for all routine tests for LP gases required by Specification D 1835.
This practice may also be used for other Natural Gas Liquid (NGL) products that are normally single phase (NGL mix, field butane, etc.), defined in other industry specifications or contractual agreements. It is not intended for non-specification products that contain significant quantities of undissolved gases (N2, CO2), free water or other separated phases, such as raw or unprocessed gas/liquids mixtures and related materials. The same equipment can be used for these purposes, but additional precautions are generally needed to obtain representative samples of multiphase products (see Appendix A of Practice D 3700).
NOTE 1 - Practice D 3700 describes a recommended practice for obtaining a representative sample of a light hydrocarbon fluid and the subsequent preparation of that sample for laboratory analysis when dissolved gases are present. Use of Practice D 1265 will result in a small but predictable low bias for dissolved gases due to the liquid venting procedure to establish the 20 % ullage.
This practice includes recommendations for the location of a sample point in a line or vessel. It is the responsibility of the user to ensure that the sampling point is located so as to obtain a representative sample.
The values stated in SI units are to be regarded as the standard. The values given in parentheses are for information only.
This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.